Stay updated on Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, reflecting a platform-level update; the study details themselves remain unchanged.
    Difference
    0.1%
    Check dated 2026-09-01T18:17:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study's list of identifiers now includes a line for '2014 ( U.S. NIH Grant/Contract )', indicating NIH funding for the trial.
    Difference
    0.1%
    Check dated 2026-08-25T20:48:33.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.5, replacing v3.6.4, indicating a deployed software update to the site rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-11T16:56:43.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, indicating a newer build of the site's underlying templates or scripts. This typically reflects minor fixes or updates to the page infrastructure rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-07-28T10:24:59.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.2 to v3.6.3, indicating a new version of the page. This update updates the documentation/version metadata without altering the study content or visible details.
    Difference
    0.1%
    Check dated 2026-07-07T02:50:42.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a newer page revision.
    Difference
    0.1%
    Check dated 2026-06-29T17:50:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.